M3 (MTHRF) Stock Price, News & Analysis

Company Overview

M3, Inc. is a Tokyo‐based company specializing in digital healthcare solutions and medical media platforms. Founded in 2000, the firm operates online networks that connect healthcare professionals with pharmaceutical and biotech companies, providing medical information, educational content and peer‐to‐peer communication tools. Over time, M3 has expanded its portfolio to encompass a broad range of services aimed at enhancing clinical decision‐making and streamlining drug development processes.

The company’s offerings include physician portals that deliver the latest research and treatment guidelines, digital marketing and e‐detailing services for life sciences companies, and real‐world evidence (RWE) analytics based on de-identified patient data. M3 also provides clinical trial support, leveraging its extensive practitioner network to facilitate patient recruitment, site management and post-marketing surveillance. Its technology‐driven approach helps clients optimize study design, accelerate timelines and meet regulatory requirements across multiple markets.

With operations spanning Japan, North America, Europe and the Asia-Pacific region, M3 serves a global customer base of healthcare professionals, pharmaceutical companies and medical device manufacturers. The company has established regional hubs in key markets, enabling localized content, market access support and compliance expertise. Its cross‐border infrastructure allows clients to harmonize launch strategies and gather insights on treatment patterns in diverse healthcare systems.

Headquartered in Tokyo and led by President and CEO Tsuyoshi Koizumi, M3 continues to invest in technology and strategic partnerships aimed at driving innovation in digital health. By integrating advanced analytics, artificial intelligence and large‐scale clinician networks, the company seeks to address evolving industry needs and support the development of new therapies worldwide.

Key Stats

• Today's Range: $8.55 to $8.55
• 50-Day Range: $8.55 to $8.55
• 52-Week Range: $8.55 to $15.25
• Volume: N/A
• Average Volume: 3,413 shs
• Market Capitalization: N/A
• P/E Ratio: 0.30
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

M3 Stock Analysis - MarketRank™

M3 scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

M3 has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

M3 has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of M3 is 0.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of M3 is 0.30, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.04.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

M3 has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in M3 has recently decreased by 20.67%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

M3 does not currently pay a dividend.

Dividend Growth

M3 does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, M3 insiders have not sold or bought any company stock.

Percentage Held by Institutions

19.63% of the stock of M3 is held by institutions.

Company Calendar

• Today: 7/28/2026
• Next Earnings (Estimated): 7/29/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MTHRF
• CIK: N/A
• Web: corporate.m3.com
• Phone: (136) 229-8900
• Fax: N/A
• Employees: 10,533
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.30
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A